$ADXS Form 8-K


Form 8-K for ADVAXIS, INC.


Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

Item 7.01 Regulation FD Disclosure.A copy of the press release of Advaxis, Inc. (the “Company”) dated June 25, 2015 relating to the announcement discussed in Item 8.01 below is attached hereto as Exhibit 99.1.

The information furnished pursuant to this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.


Item 8.01 Other Events.On June 25, 2015 at 8:30am ET, the Company will host a corporate business update conference call and webcast to review year-to-date accomplishments and key near-term goals. The Company also issued a press release announcing its business outlook, outlining various regulatory, clinical, business and operational milestones throughout the remainder of the year and into 2016.


Item 9.01. Financial Statements and Exhibits.(d) Exhibits.

The following exhibit is furnished as a part of this report

99.1 Press Release dated June 25, 2015.



Please enter your comment!
Please enter your name here